Ali Al-Khafaji, MD, MPH, FCCM

  • Professor of Critical Care Medicine and Surgery
  • Medical Director, Transplant Intensive Care Unit, UPMC Presbyterian-Montefiore

    Education & Training

  • MD, Al-Mustansiriya University, 1993
  • MPH, Health Services Research, London School of Hygiene and Tropical Medicine, 2004
  • Residency, Internal Medicine, UPMC Mercy, 1999
  • Fellowship, Critical Care Medicine, Dartmouth Medical School, 2001
  • Fellowship, Anesthesia and Critical Care, University College London, 2005
Fellow, American College of Critical Care Medicine, 2016
Pittsburgh Magazine’s list of the “Best Doctors in Pittsburgh” for 2016-2018
Representative Publications

DellaVolpe J, Al-Khafaji A. Acute Kidney Injury Before and After Liver Transplant. J Intensive Care Med. 2018 Jul 30:885066618790558. doi: 10.1177/0885066618790558. [Epub ahead of print]
Thompson J, Jones N, Al-Khafaji A, et al for the VTI-208 Study Group. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018 Mar;24(3):380-393.
Amathieu R, Al-Khafaji A, Sileanu FE, Foldes E, DeSensi R, Hilmi I, Kellum JA. Significance of oliguria in critically ill patients with chronic liver disease. Hepatology. 2017 Nov;66(5):1592-1600.
Al-Khafaji A, Elder M, Lebovitz DJ, Murugan R, Souter M, Stuart S, Wahed AS, Keebler B, Dils D, Mitchell S, Shutterly K, Wilkerson D, Pearse R, Kellum JA. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015 Mar;41(3):418-26.

► Full listing on Pub Med

Research Interests
  • Critical care hepatology
  • Post-operative care in liver transplantation
  • Acute kidney injury in patients with liver disease